Home

David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/12/07

Trade details

Type
Insider buy
Amount
$19,505.46
Shares · price
19,123 sh · $1.02 a share
Held after
2,260,541 sh
Trade date
23/12/06
Filed
23/12/07
Days to filing
1 days

Holdings up 0.9%

Insiders buying this week
1 insiders
Holding change
+0.9%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/06~24/01/05

David Lamond's recent trades

  • David Lamond

    BuyQuince Therapeutics

    $23.5K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.8K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.6K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $300

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $19.3K

    Filed 23/12/07

David Lamond, Director — bought $19.5K of Quince Therapeutics QNCX · 19,123 sh @ $1.02 | Whalegun